Iteos Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

iTeos Therapeutics

23/03/2022 21:01

* Iteos Therapeutics Inc  ITOS.OQ  reported quarterly
adjusted
earnings of $4.89​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was
for earnings of $1.28 per share.
    * Revenue was $240.50 million​;  analysts expected $85.46
million. 
    * Iteos Therapeutics Inc's reported EPS for the quarter was
$4.89​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Iteos Therapeutics Inc shares had fallen by 28.1% this
quarter.
    * The company reported quarterly net income of $184.87
million.
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $52.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 23 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated